Kairos Pharma KAPA
NYSE KAPA
$0.54 -0.06 (-10.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Kairos Pharma (KAPA) Return on Assets [ROA] (2024 - 2025)

Updated

Kairos Pharma's Return on Assets [ROA] was -88.51% in FY2025, down 17.87 percentage points from -70.64% in FY2024.

Analysis

Kairos Pharma (KAPA) Return on Assets [ROA] (2024 - 2025) Analysis & Trends

  • Per Business Quant data, Return on Assets [ROA] in earlier years was -70.64% in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 8.08%
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 4.65%
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 2.45%
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 10.60%
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 9.10%
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 9.29%
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -6.13%
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 2.14%
10 Kairos Pharma 11.24 Mn -1.17 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -61.94%
Mar 31, 2025 -48.70%
Dec 31, 2024 -44.15%
API Access

Kairos Pharma Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=KAPA&period=max&api_key=YOUR_API_KEY